Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Kertas Basuki Rachmat Indonesia Tbk. (KBRI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Kertas Basuki Rachmat Indonesia Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Kertas Basuki Rachmat Indonesia Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Kertas Basuki Rachmat Indonesia Tbk. trades at Rp50 (market cap 434.4B), while UBC Medical Indonesia Tbk. trades at Rp174 (market cap 691.25B, 635.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.

KBRILABS
Market Cap
434.4B691.25B
Volume
635.5K
Lot
6.36K
Turnover
110.15M
Average Price
173.33
Value
110.15M
Indicative Equilibrium Price
174
Indicative Equilibrium Volume
50

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

LABS
View details

About Kertas Basuki Rachmat Indonesia Tbk.

PT Kertas Basuki Rachmat Indonesia (the company) was established under its original name of PT Petroneks base on notarial deed No.21 of Mrs E Sianipar, S.H, dated on Apr 4, 1979. The Company’s articles of association has been amended several times, most recently by notarial deed No. 22 of Sutjipto, S.H., dated Feb 5, 2008, concerning among others, the change in the Company’s name.

Read more on KBRI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS